For an application to proceed to evaluation, it must meet all the eligibility criteria mentioned in the call text.

The criteria for eligibility are:

• A consortium submitting an application must be transnational, involving a minimum of three applicants employed at different organisations from at least three different countries participating in EP PerMed (see Annex 1) at the time of the application.
• One of the minimum three applicants must act as principal applicant and the other as co-applicants.
• The networking event must take place in one of the countries that are listed in Annex 1 of the call text.
• The maximum budget that can be requested per NSC application is €30,000.
• Requirements for the principal applicant (1 person):
  • The organisation of the principal applicant has to be a legal entity and established in a country listed in Annex 1.
  • The principal applicant must be a researcher that is or was acting as a coordinator or partner in a project funded by ERA PerMed or EP PerMed.
  • The principal applicant must have an employment relationship with an organisation that meets the definition of a research organisation as referred to in EU state aid legislation (Framework for state aid for research and development and innovation (2014/C 198/01). Usually, this means that the principal applicant is employed at a university.
  • The principal applicant cannot participate in more than one application as principal applicant in the NSC2025 call.
• Requirements for the co-applicants (2 – 7 persons):
  • At least one of the co-applicants (1 person) must be a researcher who is either a coordinator or a partner in a project previously funded by ERA PerMed or EP PerMed. This project must be different from the project of the principal applicant.
    • A maximum of 2 co-applicants can represent the same previously funded project.
    • The other co-applicant(s) can be:
      • A researcher from a country listed in Annex 1 who is involved in a (inter)national project related to health research towards PM approaches.
      • A translational stakeholder. The expertise of the translational stakeholder should facilitate the transition from research results into implementation in daily clinical practice. In this call, the translational expert can be a clinician or research nurse, healthcare provider, implementation specialist, Health Technology Assessment expert, citizen/patient advocacy organisation (PAO), regulator or policy maker. The role and added value of the translational stakeholder in the networking event must be described in the stakeholder analysis in the application form.

 

Sponsor Institute/Organizations: European Partnership for Personalised Medicine horizon europe

Sponsor Type: Corporate/Non-Profit

Address: Division Health Innovations for Disease Control Heinrich-Konen-Str. 1 53277 Bonn Germany

Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.

Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.

Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.

Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.

Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.

Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.

Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.